The Catalyst

Most Recent Posts

I wanted to bring to your attention a recent piece by Sarika Bansal in Forbes. Ms. Bansal's piece is entitled "Top Five Ways Big Pharma Can Address Neglected Disease." As well as making some good observations about what is needed in the effort to address neglected diseases around the world, she also does a good job of acknowledging many things that biopharmaceutical research companies are already doing.
11.28.11 | By Kate Connors
Lately, Jen's been doing a great job of highlighting both the strong need for progress in the battle against Alzheimer's Disease and the hard work that is going into fighting that battle.
11.23.11 | By Kate Connors
With Thanksgiving on the horizon, your friendly Catalyst writers took a few minutes to jot down what they're thankful for this year...with a specific mandate to not talk about innovation or advocacy! Here are our answers - we'd love to see what you're thankful for in the comments section. Preet Bilinski: I'm thankful for the health and happiness of my family and friends... for having enough of everything I need... And especially thankful for a holiday focused on chowing down on good food.
11.22.11 | By Stien Vandierendonck

Below is a guest post from Stien Vandierendonck, from National Alliance for Caregiving. Established in 1996, the Alliance is a non-profit coalition of national organizations focusing on issues of family caregiving. Alliance members include grassroots organizations, professional associations, service organizations, disease-specific organizations, a government agency, and corporations.


A few days ago, I wrote about Sabina and Mark Shalom, a caregiver and Alzheimer's patient featured in our video about this devastating disease. Sabina, like the millions of other caregivers, has great hopes that one day there will be a treatment available that can help delay or prevent the onset of Alzheimer's.


I recommend taking a look at two interesting pieces that appeared in the press over the last couple of days.


The Catalyst has featured several posts about the counterfeit medicine threat and today I want to update you on the latest development.

11.17.11 | By Preet Bilinski
Previously on the Catalyst, we shared a teaser on the National Parkinson Foundation 'Moving Day', an event to raise awareness and funds for Parkinson's disease.
A new IMS report released Monday offers suggestions for helping alleviate drug shortages, including an Early Warning System.
With Thanksgiving Day approaching, many families are beginning to prepare for their annual turkey feast and reflect on all of the things they are grateful for. Many families eagerly await the arrival of this holiday to celebrate with close friends and family, but for others it can be a difficult time, especially if a loved one is in poor health.
11.15.11 | By Greg Lopes
This week, I had a chance to catch up with Scott Williams at the Men's Health Network about the work that they do to promote health and prevention and how they believe that Medicare Part D is helping them play a role in meeting that goal. Read our chat below. Scott, please tell me a bit more about your organization.
There's an interesting interview with PhRMA President & CEO John Castellani in the most recent edition of Modern Pharmaceuticals -- a magazine covering India's growing biopharmaceutical sector. The interview covers a wide range of issues including India's need to address access to health, efforts to grow its innovative biopharmaceutical sector and the importance of protecting intellectual property rights. Check it out.
11.14.11 | By Kate Connors
In The New York Times Prescriptions blog today, writer Reed Abelson looks at a study in the New England Journal of Medicine finding that co-pays for prescription medicines can discourage patients from adhering to their prescribed treatment regimens.
The 2011 Asia Pacific Economic Cooperation (APEC) took place over the last couple of days in Hawaii. There was a lot of discussion about how to improve trade and economic opportunities among Pacific-rim countries. For technology-based businesses - like America's biopharmaceutical research companies - securing strong protections for their intellectual property (IP) rights is a key factor in their ability to successfully engage in business and trade throughout the region.
11.11.11 | By Kate Connors
In today's Washington Post, Michael Gerson writes about the promise of the current war on AIDS: "the end of the global AIDS epidemic is suddenly, unexpectedly, within sight."